This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other acute viral hepatitis
HEPATITIS_ACUTE_OTHER_VIRAL
animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
448 |
4. Check minimum number of eventsNone |
448 |
5. Include endpointsNone |
448 |
6. Filter based on genotype QC (FinnGen only) |
448 |
Control definitions (FinnGen only)
- Control exclude
- IBD_VIRAL_HEPATITIS
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- B15-B19
- Name in latin
- Alia hepatitis viralis acuta
Similar endpoints
↥List of similar endpoints to
Other acute viral hepatitis
based on the number of shared cases.
Similar with more cases:
- Other viral hepatitis
- Viral hepatitis, IBD co-morbidity
- Viral hepatitis
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 448 | 228 | 220 |
| Unadjusted period prevalence (%) | 0.09 | 0.08 | 0.10 |
| Median age at first event (years) | 34.15 | 32.50 | 35.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 401
- Matched controls
- 4010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3243.3
201.9
178
*
B17.1
ICD-10 Finland
Acute hepatitis C
+∞
170.3
151
*
0709X
ICD-9 Finland
Viral hepatitis, Unspecified viral hepatitis without mention of hepatic coma
+∞
108.4
99
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
14.3
80.8
149
159
0705A
ICD-9 Finland
Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma
+∞
69.9
65
*
B17.8
ICD-10 Finland
Other specified acute viral hepatitis
+∞
64.3
60
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
145.6
49.0
51
*
F15.1
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use
176.9
45.9
47
*
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
48.8
45.8
55
13
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
164.2
42.7
44
*
N05AH04
ATC
quetiapine; oral
5.4
41.5
150
400
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
73.9
41.0
46
7
N05BA01
ATC
diazepam; systemic, rectal
5.9
38.5
122
275
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
88.7
36.5
40
5
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
101.7
34.4
37
*
P19
ICPC
Drug abuse
31.5
34.2
45
16
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.9
30.6
68
90
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
7.1
29.2
76
128
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.9
27.8
84
172
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
9.5
26.9
57
69
Z72.2
ICD-10 Finland
Drug use
39.8
26.6
33
9
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
74.9
25.1
28
*
N05BA04
ATC
oxazepam; oral
3.4
25.0
150
592
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
37.2
24.7
31
9
F29
ICD-10 Finland
Unspecified nonorganic psychosis
8.5
24.1
54
72
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
92.5
24.0
26
*
N03AE01
ATC
clonazepam; systemic
6.9
23.9
62
103
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
49.9
23.6
28
6
N05BA12
ATC
alprazolam; oral
5.0
22.5
78
185
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
66.4
22.1
25
*
B17.2
ICD-10 Finland
Acute hepatitis E
+∞
22.1
21
*
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
41.2
22.0
27
7
N06AX11
ATC
mirtazapine; oral
2.9
21.2
173
826
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.0
21.2
72
167
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
63.6
21.1
24
*
N05CD07
ATC
temazepam; oral
4.9
21.0
74
178
3049X
ICD-9 Finland
Drug dependence, Unspecified drug dependence
116.1
20.8
22
*
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
221.0
20.8
21
*
N05AH03
ATC
olanzapine; systemic
5.6
20.5
63
130
SPAT1275
SPAT
Drug rehabilitation and replacement therapy of opioid-dependent person
77.2
19.9
22
*
N05AA02
ATC
levomepromazine; systemic
6.9
19.6
50
81
F60.2
ICD-10 Finland
Dissocial personality disorder
48.6
19.4
23
5
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
10.9
19.3
37
37
F19.30
ICD-10 Finland
Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated
+∞
18.9
18
*
F11.21
ICD-10 Finland
Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment
198.9
18.7
19
*
N07BB01
ATC
disulfiram; oral
6.4
18.6
50
87
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.5
18.5
96
328
N05AF03
ATC
chlorprothixene; systemic
9.2
18.1
38
45
F13.25
ICD-10 Finland
Addiction caused by sedative and hypnotic continuous use
55.2
18.1
21
*
F11.29
ICD-10 Finland
Addiction caused by opiates UNS
69.9
17.9
20
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
52.4
17.1
20
*
B19.9
ICD-10 Finland
Unspecified viral hepatitis without hepatic coma
+∞
16.8
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
16.4
176
948
N03AG01
ATC
valproic acid; systemic, rectal
4.6
16.4
59
144
F10.20
ICD-10 Finland
Alcohol dependence currently independent
10.1
16.2
32
34
3044A
ICD-9 Finland
Drug dependence, Amphetamine and other psychostimulant dependence
88.6
15.7
17
*
N06AA12
ATC
doxepin; systemic
6.5
15.6
41
69
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
166.2
15.6
16
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
15.9
15.1
24
16
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
59.0
14.9
17
*
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
26.2
14.8
20
8
P15
ICPC
Chronic alcohol abuse
7.1
14.7
36
55
F15.3
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state
+∞
14.7
14
*
L03AA04
ATC
NA
+∞
14.7
14
*
F10.24
ICD-10 Finland
Alcohol depence active use
12.6
14.3
25
21
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
8.1
13.9
31
41
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
55.4
13.9
16
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
8.4
13.8
30
38
B18.1
ICD-10 Finland
Chronic viral hepatitis B without delta-agent
+∞
13.6
13
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
144.7
13.5
14
*
D72
ICPC
Viral hepatitis
144.7
13.5
14
*
F60.9
ICD-10 Finland
Personality disorder, unspecified
12.1
13.5
24
21
P18
ICPC
Medication abuse
26.8
13.5
18
7
T74.1
ICD-10 Finland
Physical abuse
8.0
13.4
30
40
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
5.9
13.2
37
68
F15.5
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder
51.8
12.9
15
*
N02AX02
ATC
tramadol; systemic, rectal
2.2
12.8
185
1116
Z2446
NOMESCO Finland
Social worker
4.2
12.7
49
128
F10.25
ICD-10 Finland
Alcohol dependence continuous use
9.2
12.7
26
30
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
72.2
12.7
14
*
F11.20
ICD-10 Finland
Addiction-induced dependence caused by opiates currently independent
33.2
12.7
16
5
N06AX16
ATC
venlafaxine; oral
2.9
12.7
86
348
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.8
12.6
88
361
3043A
ICD-9 Finland
Drug dependence, Cannabis dependence
134.0
12.5
13
*
Z3231
NOMESCO Finland
Registered nurse
2.4
12.4
127
648
N05CF02
ATC
zolpidem; oral
2.7
12.2
92
395
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
27.7
12.1
16
6
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
22.1
12.1
17
8
SPAT1227
SPAT
Substance abuse rehabilitation
22.1
12.1
17
8
R50.9
ICD-10 Finland
Fever, unspecified
2.9
12.0
78
304
N05CF01
ATC
zopiclone; oral
2.3
11.8
134
718
F90.0
ICD-10 Finland
Disturbance of activity and attention
6.3
11.8
31
53
N06AB03
ATC
fluoxetine; oral
3.0
11.7
73
277
F19.26
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction
67.0
11.7
13
*
SPAT1272
SPAT
Drug screening
23.7
11.7
16
7
A46
ICD-10 Finland
Erysipelas
3.1
11.7
66
236
Z2221
NOMESCO Finland
Medical doctor
2.3
11.6
134
721
Z22.5
ICD-10 Finland
Carrier of viral hepatitis
+∞
11.5
11
*
O98.4
ICD-10 Finland
Viral hepatitis complicating pregnancy, childbirth and the puerperium
+∞
11.5
11
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
36.2
11.3
14
*
C07AA05
ATC
propranolol; systemic
2.5
11.3
102
484
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.8
11.1
31
57
N05AX08
ATC
risperidone; systemic
3.8
11.1
47
134
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.0
11.0
67
251
A02BC01
ATC
omeprazole; systemic
2.3
11.0
116
595
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.1
10.9
26
39
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
28.9
10.8
14
5
P16
ICPC
Acute alcohol abuse
8.3
10.7
23
29
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
10.7
118
615
3040A
ICD-9 Finland
Drug dependence, Opioid type dependence
61.7
10.7
12
*
A06AD11
ATC
lactulose; oral
3.1
10.7
60
213
XF400
NOMESCO Finland
ECG with 12 standard connections
2.8
10.6
74
300
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
10.5
10.6
20
20
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
10.6
64
239
N03AX16
ATC
pregabalin; oral
2.4
10.5
105
521
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.3
10.5
55
186
N06AB05
ATC
paroxetine; oral
4.0
10.5
42
114
F19.22
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication
112.9
10.5
11
*
F19.59
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS
+∞
10.5
10
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.5
10.4
18
15
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
33.5
10.4
13
*
N05BA02
ATC
chlordiazepoxide; systemic
7.8
10.3
23
31
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
10.3
89
412
N05BE01
ATC
buspirone; oral
6.1
10.2
27
47
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
41.2
10.0
12
*
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
9.9
9.9
19
20
AA1AD
NOMESCO Finland
CT of head and brain
2.4
9.8
93
449
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
9.8
163
1013
N03AX09
ATC
lamotrigine; oral
4.0
9.7
39
106
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
6.6
9.7
24
38
N06AB06
ATC
sertraline; oral
2.8
9.7
64
253
T40.6
ICD-10 Finland
Poisoning: Other and unspecified narcotics
102.4
9.5
10
*
F12.21
ICD-10 Finland
Dependence caused by cannabis currently independent but staying in a controlling environment
102.4
9.5
10
*
F13.21
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment
102.4
9.5
10
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
30.8
9.5
12
*
J01FF01
ATC
clindamycin; systemic
2.1
9.4
126
714
F12.25
ICD-10 Finland
Dependence caused by cannabis continuous use
+∞
9.4
9
*
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
+∞
9.4
9
*
N03AX12
ATC
gabapentin; oral
2.6
9.3
73
318
N05AH02
ATC
clozapine; systemic
6.5
9.2
23
37
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.2
9.2
24
41
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.5
9.1
77
349
F11.1
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, harmful use
37.6
9.1
11
*
Z71.8
ICD-10 Finland
Other specified counselling
2.2
9.0
109
590
N06AX05
ATC
trazodone; oral
7.1
9.0
21
31
ZY010
NOMESCO Finland
Hospital outpatient
3.7
9.0
38
109
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.2
8.9
47
160
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
9.8
8.9
17
18
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.3
8.8
26
52
M79.6
ICD-10 Finland
Pain in limb
2.0
8.8
152
949
S10
ICPC
Boil/carbuncle
4.1
8.8
33
85
X57
ICD-10 Finland
Unspecified privation
6.9
8.8
21
32
N05AN01
ATC
lithium; oral
5.7
8.7
24
44
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
51.1
8.7
10
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
8.7
49
174
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
8.5
63
266
A02BC02
ATC
pantoprazole; systemic
1.9
8.5
242
1796
N06AB04
ATC
citalopram; systemic
2.2
8.5
100
531
ZY000
NOMESCO Finland
Hospital inpatient
8.1
8.5
18
23
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
91.9
8.4
9
*
6611
FHL
Needle biopsy in the operating room
91.9
8.4
9
*
F19.50
ICD-10 Finland
Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic
+∞
8.4
8
*
N05AB01
ATC
dixyrazine; systemic
11.1
8.4
15
14
EBA00
NOMESCO Finland
Extraction of tooth
2.0
8.3
147
917
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.1
8.3
110
614
N06BA04
ATC
methylphenidate; oral
5.4
8.3
24
47
ZXE00
NOMESCO Finland
One hour or less
1.9
8.3
163
1062
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
7.8
8.2
18
24
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
8.2
51
193
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
17.6
8.1
12
7
N05AX12
ATC
aripiprazole; systemic
3.7
8.1
34
97
N05AB03
ATC
perphenazine; systemic, rectal
5.0
8.1
25
53
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.6
8.1
36
108
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
22.6
8.1
11
5
Y07
ICD-10 Finland
Other maltreatment
13.4
7.9
13
10
F40.1
ICD-10 Finland
Social phobias
5.0
7.9
24
50
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.0
7.9
24
50
K76.9
ICD-10 Finland
Liver disease, unspecified
8.7
7.9
16
19
Z3226
NOMESCO Finland
Physiotherapist
2.3
7.9
76
367
X99.9
ICD-10 Finland
Assault by sharp object by unknown person
45.9
7.7
9
*
A02BA02
ATC
ranitidine; systemic
2.3
7.7
75
362
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
6.9
7.7
18
27
WX110
NOMESCO Finland
Local anesthesy
1.9
7.6
287
2304
F20.9
ICD-10 Finland
Schizophrenia, unspecified
5.2
7.5
22
44
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
6.7
7.5
18
28
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.1
7.5
42
148
S02.20
ICD-10 Finland
Fracture of nasal bones, closed
7.9
7.5
16
21
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
81.5
7.4
8
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
13.7
7.4
12
9
C03CA01
ATC
furosemide; systemic
2.2
7.3
77
387
R4110
NOMESCO Finland
Physiotherapy
2.0
7.3
106
609
B17.0
ICD-10 Finland
Acute delta-(super)infection in chronic hepatitis B
+∞
7.3
7
*
0703A
ICD-9 Finland
Viral hepatitis B without mention of hepatic coma
+∞
7.3
7
*
O35.5
ICD-10 Finland
Maternal care for (suspected) damage to fetus by drugs
+∞
7.3
7
*
F11.2
ICD-10 Finland
Mental and behavioural disorders due to use of opioids, dependence syndrome
+∞
7.3
7
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
6.0
7.3
19
33
WX892
NOMESCO Finland
Monitored bed care
3.2
7.2
37
124
ZXA05
NOMESCO Finland
Left side
2.1
7.2
92
505
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.2
7.2
36
119
N06AB10
ATC
escitalopram; oral
2.0
7.2
100
565
Z04.0
ICD-10 Finland
Blood-alcohol and blood-drug test
30.6
7.2
9
*
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
20.5
7.2
10
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
7.2
41
148
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
4.3
7.1
25
61
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
7.1
78
401
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
7.1
60
273
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
7.0
36
121
-1
NOMESCO Finland
NA
1.8
7.0
149
982
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
7.0
88
478
SPAT1265
SPAT
Breathalyser
7.7
7.0
15
20
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
11.2
6.8
12
11
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
6.8
87
473
EBA05
NOMESCO Finland
Complicated extraction of tooth
2.0
6.8
94
528
2920A
ICD-9 Finland
Drug psychoses, Drug withdrawal syndrome
40.8
6.8
8
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
6.8
31
96
S06.0
ICD-10 Finland
Concussion
2.6
6.7
50
212
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.8
6.7
27
75
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.2
6.7
24
60
S18
ICPC
Laceration/cut
1.8
6.7
147
977
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
6.6
144
953
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.5
6.6
22
51
M54.5
ICD-10 Finland
Low back pain
1.8
6.6
137
891
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
6.6
206
1522
A28
ICPC
Limited function/disability NOS
2.7
6.6
43
169
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.3
6.6
31
98
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
6.6
74
382
ZXY60
NOMESCO Finland
2-person team, nurses
10.3
6.6
12
12
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
6.5
20
43
ZXD05
NOMESCO Finland
Urgent procedure
1.8
6.5
126
803
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.6
6.4
21
48
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
70.9
6.4
7
*
F11.30
ICD-10 Finland
Withdrawal symptoms caused by opiates uncomplicated
70.9
6.4
7
*
309
Kela drug reimbursment
Nalmefene and naltrexone
14.6
6.4
10
7
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
5.7
6.4
17
31
IEV99
NOMESCO Finland
Other psychiatric network intervention
11.3
6.3
11
10
N05AF01
ATC
flupentixol; systemic
9.5
6.3
12
13
WX730
NOMESCO Finland
Conventional respirator
9.5
6.3
12
13
R18
ICD-10 Finland
Ascites
9.5
6.3
12
13
B18.9
ICD-10 Finland
Chronic viral hepatitis, unspecified
+∞
6.3
6
*
0706X
ICD-9 Finland
Viral hepatitis, Unspecified viral hepatitis with hepatic coma
+∞
6.3
6
*
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
6.3
6
*
F11.26
ICD-10 Finland
Addiction caused by opiates intermittent drug addiction
+∞
6.3
6
*
3017A
ICD-9 Finland
Personality disorders, Antisocial personality disorder
+∞
6.3
6
*
F11.39
ICD-10 Finland
Withdrawal symptoms caused by opiates without information about seizures
+∞
6.3
6
*
F13.26
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics periodic addiction
+∞
6.3
6
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
6.3
66
332
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
27.1
6.2
8
*
K04.0
ICD-10 Finland
Pulpitis
2.4
6.2
54
246
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
6.2
93
538
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
6.2
144
968
WW200
NOMESCO Finland
Immunization
4.8
6.2
19
41
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.3
6.2
29
92
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.1
169
1195
D10
ICPC
Vomiting
2.9
6.1
35
126
N05AD01
ATC
haloperidol; systemic
4.5
6.1
20
46
N05BA06
ATC
lorazepam; systemic, sublingual
3.8
6.1
24
66
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.9
6.1
14
21
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.3
6.1
17
33
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.0
152
1046
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
2.6
6.0
43
179
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.0
6.0
34
121
WX290
NOMESCO Finland
Other blockade of nerve
1.7
6.0
204
1531
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
98
14
89.32
184.59
2.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
104
8
168.66
102.05
2.1
1.0
iu/ml
1265573.1
—
—
14
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
78
67
13.89
78.61
1.2
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
94
108
10.75
77.94
1.4
1.2
titre
66.3
65.6
—
8
9
(3016650) Hepatitis A virus Ab [Presence] in Serum
81
75
12.96
77.87
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
53
22
27.19
75.60
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
104
151
8.67
71.45
16.9
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
140
287
6.64
69.64
3.3
2.7
g/l
0.2
0.2
7.04
129
268
(3028707) Methadone [Presence] in Urine by Screen method
86
103
10.10
68.82
11.8
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
20
26.76
68.23
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
47
20
26.14
66.26
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
57
0
+∞
60.83
1.3
0.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
295
1242
5.03
60.83
6.9
3.4
u/l
74.4
31.5
4.32
284
1186
(3024561) Albumin [Mass/volume] in Serum or Plasma
305
1323
5.09
60.35
7.2
5.0
g/l
35.3
36.4
2.04
291
1252
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
207
696
4.67
56.44
2.0
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
98
173
6.97
55.77
11.0
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
107
209
6.41
55.04
11.1
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
228
849
4.43
53.72
7.6
3.7
%
88.6
94.0
2.67
221
836
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
345
1755
5.20
52.72
10.9
6.1
umol/l
15.6
11.3
2.45
335
1670
(3000764) Benzodiazepines [Presence] in Urine
108
223
6.06
52.28
11.2
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
108
224
6.04
52.01
11.0
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
108
226
5.98
51.49
11.2
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
170
532
4.54
50.02
2.1
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
105
222
5.87
49.39
9.4
1.5
—
—
—
0
0
(4198724)
38
23
17.96
45.79
3.7
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
43
35
13.48
44.16
1.1
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
210
875
3.64
39.39
2.6
1.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
167
607
3.79
38.44
3.2
1.8
%
1.6
1.4
3.42
149
548
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
130
399
4.18
38.09
4.9
2.8
umol/l
24.8
9.2
2.46
113
352
(3021879) Hepatitis B virus core Ab [Presence] in Serum
119
352
4.24
36.54
2.0
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
93
228
4.89
36.31
1.6
1.5
g/l
1.6
1.4
0.34
88
209
(3023183) Ammonium ion [Moles/volume] in Plasma
54
79
7.64
36.02
3.7
4.9
umol/l
42.9
38.7
0.41
47
69
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
112
328
4.22
34.72
4.0
2.5
u/l
25.6
175.2
0.52
100
280
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
54
86
7.00
33.30
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
235
1142
3.22
32.83
7.9
5.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
68
145
5.35
31.04
1.6
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
92
6.40
30.03
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
191
867
3.10
29.29
9.3
6.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
184
818
3.12
29.26
7.1
4.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
303
1778
3.18
29.22
9.7
5.8
e9/l
0.6
0.6
0.10
275
1557
(3006315) Basophils [#/volume] in Blood
303
1785
3.15
28.88
9.9
5.9
e9/l
0.0
0.0
0.29
276
1566
(3012544) pH of Venous blood
94
275
4.06
28.82
4.7
3.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
309
1845
3.17
28.67
10.9
6.3
e9/l
0.2
0.2
1.08
285
1647
(3002032) Base excess in Venous blood by calculation
92
268
4.06
28.35
4.7
3.6
mmol/l
1.2
2.1
1.30
74
216
(3019069) Monocytes/100 leukocytes in Blood
290
1679
3.06
28.29
9.5
6.1
%
8.4
8.4
0.01
281
1600
(3022096) Basophils/100 leukocytes in Blood
282
1615
3.01
27.92
9.4
5.9
%
0.7
0.7
0.01
273
1527
(3037522) Nuclear Ab [Titer] in Serum
136
524
3.29
27.34
1.4
1.4
titre
252.3
437.0
1.65
26
108
(3019198) Lymphocytes [#/volume] in Blood
306
1848
3.07
27.21
9.9
5.9
e9/l
2.0
2.0
0.19
284
1651
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
49
87
6.20
27.08
1.1
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
286
1672
2.96
26.87
9.4
5.8
%
2.7
2.9
0.90
277
1580
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
49
88
6.13
26.77
1.2
1.2
u/ml
182.2
258.5
0.96
35
52
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
267
1515
2.89
26.36
10.2
7.3
mmol/l
1.2
1.2
2.92
235
1305
(3021589) Normoblasts [#/volume] in Blood
276
1598
2.89
26.14
13.8
8.2
e9/l
0.0
0.0
0.58
242
1305
(3002030) Lymphocytes/100 leukocytes in Blood
292
1746
2.93
25.94
9.4
5.8
%
31.0
28.6
2.47
281
1660
(3018010) Neutrophils/100 leukocytes in Blood
288
1727
2.87
25.13
9.4
5.7
%
54.4
56.9
2.59
278
1646
(44816559) Phosphatidylethanol [Mass/volume] in Blood
52
107
5.37
24.55
2.1
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
323
2073
3.00
24.51
15.8
8.9
e9/l
3.8
4.1
1.19
297
1821
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
210
1082
2.77
24.47
4.1
2.7
u/l
52.0
56.2
1.30
193
1015
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
221
1172
2.75
24.28
3.4
3.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
63
155
4.57
24.09
1.4
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
195
984
2.74
23.44
3.6
3.0
e6/l
18.1
115.9
0.85
152
749
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
36
54
7.16
23.30
3.8
2.5
u/ml
7.6
3.4
0.55
36
49
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
44
83
5.77
22.79
1.1
1.5
u/ml
131.9
110.9
1.15
11
17
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
241
1368
2.65
22.63
9.5
6.4
mmol/l
1.2
1.2
2.28
225
1258
(3042936) Bacteria identified in Isolate by Culture
117
466
3.04
21.70
2.4
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
213
1164
2.58
21.28
4.3
3.4
e6/l
33.4
105.0
1.15
160
812
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
410
3.11
21.19
2.3
2.6
%
20.9
24.6
1.96
95
363
(3032080) INR in Blood by Coagulation assay
219
1215
2.57
21.16
9.2
6.5
inr
1.2
1.1
0.26
75
378
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
95
342
3.26
20.88
1.9
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
55
136
4.47
20.82
5.2
3.2
mmol/l
23.8
24.4
0.56
50
125
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
93
334
3.25
20.49
1.8
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
117
482
2.93
20.30
1.9
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
179
924
2.56
19.85
4.9
4.0
ph
7.4
7.4
0.59
33
162
(3030467) Casts [#/volume] in Urine by Automated count
176
906
2.55
19.58
3.5
2.8
e6/l
0.8
0.3
0.62
138
673
(3022948) Iron [Moles/volume] in Serum or Plasma
116
485
2.88
19.51
2.2
2.5
umol/l
13.2
14.3
0.86
111
451
(36304419) Bacteria [Presence] in Urine
174
894
2.55
19.40
3.4
2.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
109
442
2.94
19.38
2.2
2.5
g/l
2.5
2.4
0.95
104
413
(3009508) Creatinine [Moles/volume] in Urine
187
1000
2.49
19.07
9.3
3.1
mmol/l
7.7
8.3
0.88
166
853
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
118
504
2.82
19.02
2.7
2.7
e6/l
2.5
2.3
0.10
65
260
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
122
533
2.77
18.82
2.7
2.6
e6/l
1.3
0.9
0.64
66
288
(3007853) Bacteria identified in Skin by Aerobe culture
101
399
2.98
18.78
2.0
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
39
7.30
18.01
1.6
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
294
1962
2.45
17.84
8.8
4.9
mmol/l
6.6
6.6
0.11
285
1826
(3000991) Gas panel - Venous blood
74
251
3.33
17.77
14.3
9.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
205
1174
2.38
17.61
2.0
1.8
pmol/l
97.2
97.9
0.07
121
607
(3012095) Magnesium [Moles/volume] in Serum or Plasma
117
517
2.71
17.52
4.6
3.5
mmol/l
0.8
0.8
0.96
112
493
(40768441) Liver Pathology biopsy report
21
24
9.13
16.90
1.4
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
30
8.03
16.70
6.8
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
82
309
3.02
16.44
4.5
2.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
176
966
2.35
16.42
2.5
2.1
u/l
306.6
216.9
0.51
170
922
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
146
748
2.41
15.83
2.4
2.1
mg/l
2.8
3.0
0.38
124
649
(3007164) IgA [Mass/volume] in Serum or Plasma
155
817
2.37
15.75
1.7
1.4
g/l
2.5
2.4
0.13
108
527
(3022217) INR in Platelet poor plasma by Coagulation assay
83
330
2.86
15.04
10.8
17.1
inr
1.1
1.3
—
8
44
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
361
2743
2.63
15.04
7.1
3.0
u/l
86.8
46.4
6.98
349
2620
(3026008) Bacteria identified in Urine by Culture
154
827
2.31
14.84
3.7
2.6
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
132
668
2.38
14.55
3.0
2.4
e6/l
12.6
5.3
2.29
121
592
(3026782) Osmolality of Urine
126
632
2.38
14.11
3.2
2.5
mosm/kgh2o
528.8
568.7
0.98
113
546
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
150
3.55
13.71
1.4
1.4
miu/ml
157.8
233.7
0.71
22
80
(3037467) Urinalysis macro (dipstick) panel - Urine
323
2395
2.25
13.24
5.0
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
258
1758
2.10
13.13
4.0
3.1
estimate
0.0
0.0
0.00
45
309
(3013707) Erythrocyte sedimentation rate by Westergren method
346
2646
2.35
13.05
4.6
3.8
mm/h
12.6
9.8
3.13
325
2463
(3035350) Ketones [Presence] in Urine by Test strip
255
1735
2.09
12.97
3.9
3.1
estimate
0.0
0.0
0.00
47
324
(3021601) Nitrite [Presence] in Urine by Test strip
255
1738
2.08
12.87
5.4
4.3
estimate
0.0
0.0
0.50
48
331
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
153
3.39
12.61
1.7
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
22
39
5.88
12.06
34.0
19.5
nmol/l
1287.6
1475.9
0.38
22
39
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
19
29
6.80
12.01
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
124
657
2.23
11.98
1.6
1.4
nmol/l
17.6
21.0
2.19
112
568
(3009466) Valproate [Moles/volume] in Serum or Plasma
27
59
4.81
11.81
5.3
6.7
umol/l
315.0
369.2
0.95
22
51
(3023511) Choriogonadotropin [Units/volume] in Urine
36
99
3.87
11.75
2.0
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
427
3682
4.41
11.74
26.3
13.0
mmol/l
139.2
139.7
3.42
417
3589
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
19
30
6.57
11.64
1.4
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
428
3702
4.50
11.59
26.2
13.0
mmol/l
3.9
4.0
0.54
417
3594
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
28
65
4.53
11.39
3.9
2.7
u/ml
0.3
0.3
—
7
35
(3015377) Calcium [Moles/volume] in Serum or Plasma
169
1026
2.04
11.35
3.9
3.4
mmol/l
2.4
2.4
0.05
150
917
(3044640) Blood type and Crossmatch panel - Blood
170
1037
2.03
11.25
3.1
2.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
8
20.67
11.20
1.3
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26
58
4.70
11.10
3.6
2.3
titre
1160.0
1744.0
—
8
5
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
102
513
2.28
11.09
2.6
2.8
mmol/l
2.4
2.4
0.18
91
448
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
178
3.04
10.94
1.6
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
407
3449
2.97
10.74
21.2
10.4
ml/min/173m2
91.1
88.4
1.55
351
2807
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
40
126
3.39
10.69
1.6
1.7
—
216.7
—
0
6
(3011397) Hemoglobin [Presence] in Urine by Test strip
135
769
2.08
10.68
3.5
3.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
74
328
2.50
10.65
14.5
10.6
mmol/l
1.6
1.1
0.65
61
267
(3021440) Promyelocytes/100 leukocytes in Blood
61
247
2.70
10.54
5.4
4.3
%
0.0
0.1
2.18
23
68
(3017181) Myelocytes/100 leukocytes in Blood
64
269
2.61
10.27
5.3
4.1
%
0.4
0.8
1.04
25
78
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
13
9.46
9.91
2.8
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
109
587
2.13
9.91
3.4
3.6
ng/l
186.1
397.4
0.75
71
418
(3025159) Blasts/100 leukocytes in Blood
58
237
2.66
9.83
5.6
4.3
%
0.0
0.0
0.80
19
55
(40760892) CBC W Ordered Manual Differential panel - Blood
146
885
1.96
9.55
6.8
4.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
134
795
1.98
9.29
2.8
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
133
794
1.96
9.02
6.4
3.2
kg/l
1.0
1.0
—
10
103
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
421
3710
3.24
8.84
24.3
11.9
mg/l
21.6
22.3
0.19
365
2857
(3027945) Reticulocytes/100 erythrocytes in Blood
66
302
2.39
8.81
3.0
3.0
%
1.8
1.8
0.08
60
278
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
15
25
6.17
8.70
15.5
8.8
u/ml
48.7
48.4
—
10
11
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
132
795
1.94
8.67
1.7
1.7
mg/l
1.1
1.1
0.11
107
596
(40768797) Stomach Pathology biopsy report
88
463
2.12
8.39
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
337
2733
1.94
8.36
4.3
3.9
pmol/l
14.6
14.5
0.18
309
2515
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
30
5.49
8.26
3.8
2.8
%
27.6
41.2
—
6
6
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
385
3303
2.18
7.72
5.4
4.5
mu/l
1.8
2.2
0.62
365
3083
(3002179) Metamyelocytes/100 leukocytes in Blood
55
247
2.40
7.64
4.5
4.2
%
0.4
0.4
0.01
17
53
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
102
586
1.96
7.59
2.7
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
30
98
3.21
7.58
2.2
2.4
g/l
3.7
3.7
0.00
30
93
(3044889) 12 lead EKG panel
306
2444
1.80
7.51
3.9
3.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
27
85
3.32
7.24
1.9
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
219
1607
1.71
7.14
3.1
2.8
ug/l
173.3
110.6
1.63
205
1513
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
219
1609
1.71
7.10
4.2
4.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
195
1393
1.71
6.97
2.6
2.2
nmol/l
69.3
73.6
1.24
179
1273
(3019309) Folate [Moles/volume] in Red Blood Cells
88
495
1.97
6.92
1.6
1.7
nmol/l
1152.3
1202.7
0.19
65
385
(3000494) Fungus identified in Specimen by Culture
78
421
2.03
6.89
1.4
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
63
3.62
6.80
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
140
918
1.76
6.77
4.4
3.4
estimate
0.0
0.0
0.88
47
324
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
33
122
2.84
6.76
1.7
2.3
g/l
1.6
1.4
0.59
28
110
(36660697) Celiac disease serology panel - Serum
64
323
2.14
6.74
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
54
3.83
6.71
1.9
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
41
4.27
6.60
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
107
653
1.84
6.54
3.0
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
65
3.51
6.50
5.8
2.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
55
266
2.22
6.43
3.2
2.6
ml/min/173m2
73.1
72.9
0.01
21
120
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
136
897
1.74
6.38
1.4
1.2
u/ml
1.1
2.4
0.98
28
251
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
332
2.08
6.27
2.8
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
99
2.95
6.22
2.3
1.8
g/l
7.5
7.4
0.04
20
79
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
99
2.95
6.22
2.3
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
99
2.95
6.22
2.3
1.8
g/l
3.9
4.0
0.04
20
73
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
19
5.91
6.13
1.0
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
26
89
3.04
6.10
1.0
1.3
e6/l
33.1
9.2
0.48
20
71
(3037121) Protein [Mass/volume] in Urine
30
114
2.75
5.86
4.0
4.2
g/l
0.1
0.2
0.96
19
55
(3052851) Hemolysis interference index of Serum or Plasma
27
97
2.90
5.84
4.1
3.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
53
263
2.15
5.82
2.8
1.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
46
219
2.23
5.59
3.7
4.2
ng/l
85.6
86.3
0.02
41
200
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
219
2.23
5.59
1.4
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
83
3.00
5.55
2.3
2.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
91
2.85
5.29
2.2
1.9
g/l
3.3
3.1
0.36
20
75
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
37
165
2.35
5.23
18.8
14.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
53
276
2.04
5.14
4.0
4.4
ug/l
14.7
23.4
0.18
41
226
(3004588) Protein electrophoresis panel - Serum or Plasma
37
167
2.32
5.10
2.4
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
186
1397
1.57
4.99
4.4
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
61
3.21
4.97
1.8
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
72
3.01
4.94
1.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
73
2.97
4.83
1.6
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
64
3.06
4.61
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
64
3.06
4.61
1.3
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
110
741
1.64
4.60
2.7
3.1
ng/l
1111.2
839.5
0.38
96
605
(3017509) Phencyclidine [Presence] in Urine
7
5
14.19
4.59
7.9
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
127
887
1.60
4.59
3.2
2.4
umol/l
341.0
5849.4
3.11
114
787
(3020682) Albumin/Creatinine [Ratio] in Urine
129
911
1.58
4.43
4.6
4.1
mg/mmol
15.5
11.5
0.34
89
591
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
164
1227
1.53
4.34
3.6
3.1
ng/l
52.5
34.0
0.37
97
742
(40767503) Oxygen content in Capillary blood by calculation
16
51
3.22
4.25
2.9
2.2
%
16.5
16.6
—
8
24
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
36
3.69
4.23
1.7
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
46
3.34
4.22
1.9
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
52
3.15
4.12
1.5
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
20
75
2.74
4.04
1.2
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
44
234
1.98
4.04
1.8
2.3
ug/l
6.3
9.6
0.92
36
212
(40761511) CBC panel - Blood by Automated count
422
3938
2.23
4.02
20.0
10.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
129
934
1.54
3.91
1.9
1.7
mmol/l
1.6
1.5
0.60
116
806
(3012516) Albumin [Mass/volume] in Urine
121
864
1.55
3.90
4.1
3.4
mg/l
607.8
304.3
0.25
87
567
(40761535) Cells panel - Urine sediment
46
252
1.92
3.89
3.9
3.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
96
652
1.60
3.84
1.4
1.3
iu/ml
23.3
27.5
0.32
32
212
(3020891) Body temperature
25
108
2.39
3.83
6.6
5.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
128
2.27
3.79
2.2
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
55
2.98
3.77
1.7
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
45
3.18
3.68
1.4
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
16
5.72
3.67
2.6
3.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
30
3.73
3.66
2.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
121
1602
0.66
3.58
3.0
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
26
3.91
3.54
1.0
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
349
1.73
3.38
2.4
2.3
nmol/l
12.5
13.6
0.39
48
327
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
59
2.78
3.36
1.9
2.1
g/l
123.1
130.5
—
10
40
(3036481) Cortisol [Moles/volume] in Serum or Plasma
56
344
1.72
3.29
2.4
2.2
nmol/l
377.7
384.9
0.10
50
319
(40768443) Skin Pathology biopsy report
27
130
2.15
3.25
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
38
3.22
3.23
1.4
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
38
3.22
3.23
1.2
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
11
6.44
3.19
2.0
4.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
211
1.88
3.11
1.6
3.1
e9/l
78.6
74.1
0.29
30
160
(4281824)
10
29
3.50
3.06
1.5
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
16
5.07
3.06
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
34
183
1.93
3.06
1.7
1.6
mu/l
379.8
292.0
0.89
27
167
(3037756) Immunofixation for Serum or Plasma
14
51
2.80
3.01
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
32
564
0.53
3.01
1.3
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
40
3.06
2.99
1.6
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
5
10.09
2.98
3.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
382
3520
1.58
2.96
4.9
3.9
mmol/l
6.2
5.9
1.91
359
3283
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
342
0.42
2.92
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
30
3.39
2.92
1.5
2.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
30
3.39
2.92
1.7
1.4
%
10.4
12.1
—
10
30
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
313
2777
1.42
2.92
3.5
3.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
64
2.56
2.90
2.2
3.4
e9/l
4.1
4.1
0.04
16
64
(44790049)
12
41
2.98
2.88
1.8
1.6
—
—
—
0
0
(44790047)
12
41
2.98
2.88
1.8
1.6
—
—
—
0
0
(44790048)
12
41
2.98
2.88
1.8
1.6
—
—
—
0
0
(44806118)
12
41
2.98
2.88
1.8
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
13
5.45
2.88
4.9
6.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
9
6.74
2.87
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
181
1.89
2.82
2.4
2.8
mmol/l
1.4
1.2
0.23
24
133
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
65
2.52
2.82
2.2
3.7
%
54.6
56.9
0.33
16
65
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
31
3.28
2.79
1.7
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
60
2.55
2.73
1.0
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
24
3.80
2.68
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
170
1.88
2.66
3.6
2.3
u/l
119.2
3079.2
—
8
67
(1616796) Gas panel - Central venous blood
15
61
2.51
2.64
3.1
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
80
2.30
2.64
1.2
2.1
nmol/l
0.7
0.8
0.51
11
70
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
361
3310
1.47
2.63
6.6
5.0
mmol/mol
40.1
39.2
0.78
342
3136
(3042111) Morphology [Interpretation] in Bone marrow Narrative
11
38
2.94
2.60
1.6
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
15
62
2.47
2.56
4.0
2.2
mmol/l
2.4
2.6
—
8
40
(40760888) Immunoglobulin light chains.free panel - Serum
14
56
2.55
2.55
3.1
2.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
33
3.08
2.54
1.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
26
3.51
2.49
1.0
1.3
mmol/l
1.8
1.8
—
9
26
(3009343) pH of Capillary blood
33
189
1.81
2.49
2.4
2.8
ph
7.4
7.4
—
5
21
(3044242) Glucose [Moles/volume] in Arterial blood
7
16
4.43
2.48
4.7
5.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
483
0.55
2.45
1.5
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
8
6.30
2.37
3.8
2.1
%
44.2
52.9
—
5
8
(3022621) pH of Urine by Test strip
33
193
1.77
2.33
2.9
2.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
23
3.52
2.28
1.6
2.3
pg
32.6
33.8
—
8
23
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
23
3.52
2.28
1.3
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
25
135
1.90
2.27
1.7
1.4
g/l
1.2
1.2
0.23
25
126
(3025941) Bacteria identified in Stool by Culture
36
218
1.71
2.27
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
18
3.93
2.26
2.7
2.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
18
3.93
2.26
1.1
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
29
3.15
2.23
2.9
2.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
48
2.54
2.20
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
48
2.54
2.20
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
42
2.66
2.20
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.04
2.16
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
30
3.04
2.16
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.04
2.16
1.0
1.2
—
—
—
0
0
(4027681)
9
31
2.94
2.08
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
31
2.94
2.08
1.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
31
2.94
2.08
1.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
31
2.94
2.08
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
31
2.94
2.08
1.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
10
5.04
2.07
3.0
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
15
4.04
2.04
1.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
15
4.04
2.04
1.2
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
15
4.04
2.04
1.2
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
32
2.85
2.01
1.2
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
32
2.85
2.01
1.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
383
3599
1.44
2.00
27.8
12.5
%
39.2
41.1
4.20
302
2896
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
84
2.06
1.98
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
135
1.82
1.95
1.4
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
11
4.58
1.94
1.2
1.2
ug/l
14.1
8.9
—
5
11
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
11
4.58
1.94
1.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
27
3.00
1.94
1.1
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
71
2.15
1.94
1.5
1.9
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
33
2.76
1.94
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
16
3.79
1.94
1.3
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
16
3.79
1.94
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
66
479
1.44
1.93
2.0
1.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
10
39
2.60
1.93
1.1
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
39
2.60
1.93
1.2
1.2
nmol/l
1.1
1.5
—
10
34
(3041096) Erythrocytes [Presence] in Urine by Automated
127
1029
1.33
1.91
4.2
2.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
34
2.68
1.87
4.7
3.5
nmol/l
2.5
3.0
—
9
34
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
46
2.43
1.86
1.3
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
160
1.73
1.86
1.6
1.4
u/l
10.3
9.0
0.16
20
129
(3015171) Extractable nuclear Ab [Units/volume] in Serum
26
153
1.74
1.84
1.1
1.3
—
2.5
—
0
11
(3000330) Specific gravity of Urine by Test strip
24
138
1.78
1.83
4.3
3.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
12
4.20
1.83
4.0
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
53
2.30
1.82
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
53
2.30
1.82
1.2
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
23
3.07
1.80
1.7
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
23
3.07
1.80
1.7
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
38
249
1.57
1.80
1.3
1.3
—
31.2
—
0
12
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
29
2.79
1.80
1.8
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
29
178
1.67
1.78
8.5
8.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
36
2.53
1.75
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
30
2.70
1.73
2.3
4.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
24
2.95
1.73
1.1
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
68
2.09
1.72
1.5
1.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
127
1.77
1.67
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
224
0.48
1.66
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
43
296
1.50
1.65
4.9
3.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
52
374
1.44
1.61
9.0
6.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
63
2.10
1.61
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
32
2.53
1.60
1.3
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
26
2.72
1.58
1.1
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
20
3.03
1.58
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
50
2.23
1.58
2.5
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
21
2.88
1.51
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
21
2.88
1.51
5.7
2.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
38
2.40
1.46
1.2
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
22
2.75
1.44
1.0
1.1
iu/ml
438.5
185.5
—
6
22
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
119
1.71
1.40
1.6
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
20
119
1.71
1.40
1.6
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
119
1.71
1.40
1.5
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
10
47
2.15
1.34
1.6
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
9
42
2.17
1.34
3.4
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
9
42
2.17
1.34
3.4
2.6
mmol/l
4.1
4.0
—
9
42
(3035285) Chloride [Moles/volume] in Venous blood
9
42
2.17
1.34
3.4
2.6
mmol/l
107.4
106.2
—
9
42
(3023410) Appearance of Cerebral spinal fluid
9
42
2.17
1.34
1.3
1.5
—
—
—
0
0
(4306422)
12
61
1.99
1.34
1.1
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
126
1066
1.25
1.32
1.4
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
129
1.66
1.32
1.6
2.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
24
2.52
1.31
1.8
3.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
102
843
1.27
1.30
1.7
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
34
2.38
1.29
1.6
2.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
62
1.96
1.29
1.2
1.2
u/ml
5.4
2.7
—
5
19
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
62
1.96
1.29
2.3
2.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
48
2.11
1.28
1.5
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
48
2.11
1.28
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
158
1379
1.23
1.24
2.0
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
108
1.69
1.24
1.6
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
108
1.69
1.24
2.9
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
37
2.18
1.22
3.9
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
19
2.65
1.22
1.0
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
19
2.65
1.22
2.2
3.7
u/ml
1974.4
570.2
—
5
19
(3045788) Cell count panel - Pleural fluid
5
19
2.65
1.22
1.6
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
109
1.68
1.20
1.3
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
26
2.32
1.19
1.7
1.6
umol/l
13.4
10.2
—
6
26
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
233
1.45
1.17
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
30
2.35
1.12
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
373
3570
1.27
1.09
4.2
3.6
mmol/l
1.4
1.3
1.50
349
3352
(3025130) Human papilloma virus identified in Specimen
11
59
1.89
1.08
1.8
1.8
—
—
—
0
0
(4035726)
37
272
1.39
1.07
1.5
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
77
633
1.26
1.04
1.7
1.6
pmol/l
101470995.3
9107904.9
0.43
68
549
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
109
0.45
1.02
1.0
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
115
1.59
1.01
1.5
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
32
235
1.39
0.94
2.9
3.6
pmol/l
4.7
4.6
0.26
24
208
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
77
641
1.24
0.94
1.3
1.3
u/ml
1.1
8.0
3.39
23
268
(3005033) Fetal Nuchal fold Thickness US
5
101
0.49
0.90
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
101
0.49
0.90
1.8
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
30
220
1.39
0.90
1.3
1.4
iu/l
26.3
23.8
0.14
25
187
(4094501)
5
104
0.47
0.90
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
152
1.47
0.90
2.3
2.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
127
0.54
0.89
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
105
0.47
0.89
1.8
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
111
1.55
0.89
1.4
1.7
—
—
—
0
0
(4062490)
8
43
1.88
0.87
1.0
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
64
1.74
0.87
1.5
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
64
1.74
0.87
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
11
65
1.71
0.83
1.2
1.2
u/ml
2.7
4.5
—
6
29
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
387
3748
1.24
0.81
5.2
4.3
mmol/l
2.7
2.9
3.22
359
3521
(3002256) Pathology report gross observation
51
413
1.27
0.80
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
199
0.64
0.80
1.2
1.1
—
—
—
0
0
(3013512) EKG study
98
852
1.19
0.79
4.0
3.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
34
1.77
0.76
7.5
4.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
72.2
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
83
1.58
0.75
1.2
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
75
1.62
0.75
6.9
4.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
24
2.10
0.74
2.2
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
24
2.10
0.74
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
231
1.32
0.70
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
27
1.86
0.68
1.6
2.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
27
1.86
0.68
8.8
4.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
4.8
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
120
0.58
0.68
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
120
0.58
0.68
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
120
0.58
0.68
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
120
0.58
0.68
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
28
1.79
0.66
1.8
2.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
62
1.63
0.65
1.0
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
154
0.64
0.65
1.1
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
79
1.53
0.63
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
60
512
1.20
0.61
2.2
2.3
ug/g
101.9
112.4
0.14
55
412
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
381
3708
1.18
0.61
4.8
4.0
mmol/l
4.5
4.8
5.53
358
3505
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
40
1.51
0.51
1.7
1.3
nmol/l
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
64
1.41
0.51
1.2
1.0
—
12.7
—
0
5
(3000492) Spirometry study
50
428
1.19
0.51
1.9
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
25
198
1.28
0.50
1.2
1.1
—
167.3
—
0
7
(4034850)
17
127
1.35
0.50
13.5
8.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
136
1.34
0.50
2.4
2.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
47
401
1.19
0.50
1.4
1.3
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
7
47
1.50
0.47
1.6
1.3
nmol/l
0.6
0.5
—
7
42
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
74
664
1.14
0.43
2.4
2.6
ug/l
0.7
0.7
0.20
48
367
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
58
1.39
0.41
1.1
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
377
3693
1.13
0.40
4.7
3.9
mmol/l
1.4
1.4
2.79
356
3478
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
5
34
1.48
0.40
1.2
1.1
—
0.1
—
0
6
(3039443) Prostate specific Ag panel - Serum or Plasma
7
101
0.69
0.40
1.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
121
1124
1.10
0.39
4.3
3.9
ug/l
1.9
1.8
0.15
105
1027
(3045414) Leukocytes [Presence] in Urine
18
144
1.26
0.36
1.3
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.7
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
145
1.25
0.34
1.6
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
136
1.26
0.34
2.4
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
379
0.86
0.32
3.6
3.8
%
30.4
31.1
0.16
25
257
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
54
1.30
0.30
1.4
1.3
u/l
14.7
14.3
—
7
46
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
195
0.81
0.29
1.9
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
76
1.32
0.28
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
65
1.23
0.27
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
82
0.73
0.24
1.2
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
524
0.91
0.23
1.4
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
7.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
0
12
0.00
0.21
0.0
2.1
—
198.0
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
22.8
—
0
13
(3037556) Urate [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
70
1.15
0.16
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
82
1.10
0.15
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
259
0.92
0.10
1.8
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(4268621)
5
46
1.09
0.09
2.8
2.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(4010399)
25
234
1.07
0.08
1.6
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
65
1.08
0.08
1.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
21
221
0.95
0.04
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
90
890
1.01
0.02
4.0
3.5
%
24.3
21.2
0.71
35
345
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
117
0.94
0.01
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
428
0.98
0.01
1.9
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
61
603
1.01
0.01
1.6
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
96
1.04
0.00
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
22
215
1.02
0.00
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
27
275
0.98
0.00
3.2
4.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
284
0.98
0.00
1.3
1.2
iu/ml
131.6
145.5
—
9
119
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
2.0
—
0
9
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
61
0.98
0.00
1.2
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
12.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
10.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
4.4
—
0.4
—
0
5
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
52.4
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
10.9
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
3.0
—
5.8
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
4.0
—
0
8
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
6
68
0.88
0.00
1.3
1.1
u/ml
—
3.4
—
0
17
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
63.5
—
0
6
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
10.2
—
0
5
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HEPATITIS_ACUTE_OTHER_VIRAL – Other acute viral hepatitis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).